Switched Memory B-cells as a Marker for Humoral Immune System Recovery in Patients With Secondary Antibody Deficiency Due to Hematological Malignancies
Clinical trial NCT05612607 · UNKNOWN
Trial details
- NCT number
- NCT05612607
- Sponsor
- Ottawa Hospital Research Institute
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-10
- Primary completion
- 2023-10-10
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.